Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-03-18

Clinical Trial Update: Tolerance to Residual Astigmatism in Eyes With Vivity®

View source ↗

Summary

Clinical trial update on tolerance to residual astigmatism in eyes implanted with Vivity intraocular lenses; study completed with results posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vivity

Snippet

Sponsor: Clínica Rementería | Conditions: Lenses, Intraocular | Status: COMPLETED | Results posted: 2024-03-18